Japanese Sterile Drugmaker Toyobo Hit with 11-Observation 483

Dirt floating in so-called sterile vials and other serious quality lapses led the FDA to hit sterile drug manufacturer Toyobo of Otsu, Japan, with an 11-observation Form 483.
Source: Drug Industry Daily